Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAP3K11 |
| Upstream (Parents) |
|---|
| (<<) ATN1 → MAP3K11 |
| (<<) B3GNT2 → MAP3K11 |
| (<<) BAD → MAP3K11 |
| (<<) DHX9 → MAP3K11 |
| (<<) HGS → MAP3K11 |
| (<<) LRP5 → MAP3K11 |
| (<<) MAP3K2 → MAP3K11 |
| (<<) PRKCSH → MAP3K11 |
| (<<) RPS12 → MAP3K11 |
| (<<) RPS6KA2 → MAP3K11 |
| (<<) SMAD2 → MAP3K11 |
| (<<) TCF4 → MAP3K11 |
| (<<) TSG101 → MAP3K11 |
| (<<) WWTR1 → MAP3K11 |
| Downstream (Children) |
|---|
| MAP3K11 → BBS1 (>>) |
| MAP3K11 → BMP8B (>>) |
| MAP3K11 → CASP4 (>>) |
| MAP3K11 → CTRB2 (>>) |
| MAP3K11 → HPS6 (>>) |
| MAP3K11 → MAP3K1 (>>) |
| MAP3K11 → MAP3K14 (>>) |
| MAP3K11 → MCL1 (>>) |
| MAP3K11 → RPS6KA4 (>>) |
| MAP3K11 → SGSH (>>) |
